BCL3 and colorectal carcinoma: Furthermore, BCL-3 appears to still modulate β-catenin/TCF-mediated transcription downstream of mutated APC (SW1463, SW620) and β-catenin (LS174T), two of the most frequent mutations in CRC (Cancer Genome Atlas Network, 2012).